The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. clinical trials
13 indexed studies · 0 currently recruiting
- CompletedPhase I
Phase I trial HMR code: 25-001
This early-stage study is looking for healthy volunteers. It's a 'Phase 1' trial, which usually means researchers are testing a new treatment or medicine for the first time in people. More details about the study will be shared later.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Phase 1 trial HMR code: 25-006
This early-stage study, called HMR 25-006, is looking for healthy female volunteers. The main goal is to test a new treatment for the first time in people. More detailed information about the study will be shared later, within 30 months after it has finished.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Phase I Trial: Quotient Code QSC301789
This early-stage study, called Quotient Code QSC301789, is looking into a new treatment. We don't have all the details yet, as they will be shared later. It involves adults aged 18 to 55, both men and women. We'll know more about the specific treatment and its purpose after the study is completed.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - RecruitingPhase I
Phase I Study (QSC303441)
This early-stage study is looking for healthy volunteers aged 18-55. It's a 'Phase 1' trial, which usually tests new medicines for safety. Full details will be shared later, after the trial finishes.
For: Healthy volunteersUnited Kingdom · England - RecruitingPhase I
Phase I Study (PHU-001)
This is an early-stage study, called Phase I, looking at a new treatment or medicine. The full details are not yet available but will be shared within 30 months after the study finishes. It involves adults aged 18 to 90, both men and women.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Trial: Sponsor code: X11-201-00001
This early-stage study, called X11-201-00001, is looking into a new treatment. We can't share all the details yet, as they will be made public within 30 months after the study finishes. This is a very early step in understanding how this new treatment works and if it's safe.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom - CompletedPhase I
Phase I Trial: Quotient Code QSC301642
This early-stage study, called QSC301642, is testing a new treatment. It's for men aged 30-65. More details will be shared within 30 months after the study finishes. This is a common practice for new drug development.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I trial HMR code: 25-004
This early-stage study is looking for healthy women to help test a new treatment. We don't have all the details yet, but the aim is to see if the treatment is safe in people. More information will be shared after the study is finished.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Phase I Trial: Quotient Code QSC302246
This early-stage study, called QSC302246, is a 'Phase I' trial. This means it's one of the first human tests of a new treatment. We don't have all the details yet, but they will be shared within two-and-a-half years after the study finishes. Only men can take part.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Study: QSC301634
This early-stage study, called QSC301634, is looking into a new treatment. We don't have all the details yet, as they'll be shared later. It involves adults aged 18 to 55.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - RecruitingPhase I
Phase I trial: QSC303485
This early-stage study, called QSC303485, is looking into a new treatment. We don't have all the details yet, but they will be shared within 30 months after the study finishes. It's open to adults aged 18 to 65, both men and women.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Trial: Quotient Code QSC301409
This early-stage study, called Quotient Code QSC301409, is looking into a new treatment. We don't have all the details yet, but they will be made public within 30 months after the study finishes. It's for men aged 30 to 65 years old.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - RecruitingPhase I
Phase I Trial: Quotient Code QSC303820
This early-stage study, called QSC303820, is testing a new treatment or medicine for the first time in people. The aim is to check if it's safe and how the body handles it. More details about what the study is for will be shared later, within 30 months after it finishes.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England